Why the study?
Does Trypanosoma cruzi soluble extract antigen (TCSE) protect against lethal infection in CBA/J mice?
Does Trypanosoma cruzi soluble extract antigen (TCSE) protect against lethal infection in CBA/J mice?
TCSE induces protective immunity against lethal T. cruzi infection in mice, which is dependent on IFN-gamma production.
Answers are grounded in this paper and cite their sources.
TCSE confers IFN-gamma-dependent protection in a murine T. cruzi model; leaves open translation to human Chagas disease or vaccine development.
CBA/J mice can be protected against lethal infection with Trypanosoma cruzi by treatment using T. cruzi soluble extract antigen (TCSE). In vivo administration of TCSE (400 microg/mouse) into naive mice increased the cellular proliferative response to Con A and elevated the levels of IFN-gamma. The production of IFN-gamma was extremely important in controlling the replication of the parasite since the protective activity of TCSE was completely abrogated by in vivo treatment with an anti IFN-gamma neutralizing antibody. These results suggest that depending on the level, cytokine production results in the control of replication of the parasite in experimental Chagas' disease.
No takes yet. Share an insight, caveat, or question.
Garcia et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: